YU69400A - Biorazgradivi alginatni gelovi sa kontinualnim oslobađanjem - Google Patents
Biorazgradivi alginatni gelovi sa kontinualnim oslobađanjemInfo
- Publication number
- YU69400A YU69400A YU69400A YU69400A YU69400A YU 69400 A YU69400 A YU 69400A YU 69400 A YU69400 A YU 69400A YU 69400 A YU69400 A YU 69400A YU 69400 A YU69400 A YU 69400A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- alginate gels
- biodegradable sustained
- release alginate
- release
- sustained
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Biological Depolymerization Polymers (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Fats And Perfumes (AREA)
- Materials For Medical Uses (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Ovaj pronalazak se odnosi na formulacije sa kontinualnim oslobadjanjem koje koriste biorazgradive alginatne gelove ili čestice biorazgradivog alginata, i na postupke njihovog dobijanja.[The present invention relates to sustained-release formulations using biodegradable alginate delayed gels or particles and methods thereof.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/080,832 US6432449B1 (en) | 1998-05-18 | 1998-05-18 | Biodegradable sustained-release alginate gels |
Publications (2)
Publication Number | Publication Date |
---|---|
YU69400A true YU69400A (sh) | 2003-02-28 |
RS49841B RS49841B (sr) | 2008-08-07 |
Family
ID=22159900
Country Status (25)
Country | Link |
---|---|
US (2) | US6432449B1 (sh) |
EP (1) | EP1079811B1 (sh) |
JP (1) | JP2002515419A (sh) |
KR (1) | KR20010025023A (sh) |
CN (1) | CN1309556A (sh) |
AT (1) | ATE343378T1 (sh) |
AU (1) | AU3993999A (sh) |
BG (1) | BG65397B1 (sh) |
BR (1) | BR9910553A (sh) |
CA (1) | CA2331446C (sh) |
CY (1) | CY1105944T1 (sh) |
DE (1) | DE69933763T2 (sh) |
DK (1) | DK1079811T3 (sh) |
EA (1) | EA003670B1 (sh) |
ES (1) | ES2275341T3 (sh) |
HU (1) | HUP0101895A3 (sh) |
IL (1) | IL139617A0 (sh) |
NO (1) | NO20005564L (sh) |
NZ (1) | NZ507943A (sh) |
PL (1) | PL199499B1 (sh) |
PT (1) | PT1079811E (sh) |
RS (1) | RS49841B (sh) |
SK (1) | SK16752000A3 (sh) |
WO (1) | WO1999059549A1 (sh) |
ZA (1) | ZA200006299B (sh) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20010007673A1 (en) * | 1999-11-12 | 2001-07-12 | Merrill Seymour Goldenberg | Sustained-release delayed gels |
KR100426636B1 (ko) * | 2001-05-18 | 2004-04-08 | 한국과학기술연구원 | 주사 가능한 젤 상의 조성물 및 그의 제조방법 |
WO2002100425A1 (en) * | 2001-06-11 | 2002-12-19 | Ltt Institute Co., Ltd. | Aggregate composition for sustained-release preparation, process for producing the same, and sustained-release preparation containing the same |
WO2003062199A2 (en) * | 2002-01-16 | 2003-07-31 | Agency For Disease Diagnosis And Prevention | Pace-a microspheres for delivery of antigens |
US6592852B1 (en) * | 2002-04-25 | 2003-07-15 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Zinc citrate beads in oral compositions |
KR100523953B1 (ko) * | 2002-08-27 | 2005-10-25 | 주식회사 엘지생명과학 | 천연다당류와 히알루론산의 마이크로비드 및 이의 제조 방법 |
KR100507545B1 (ko) * | 2002-09-03 | 2005-08-09 | 주식회사 엘지생명과학 | 히알루론산 유도체 및 그의 제조방법 |
JP4459543B2 (ja) * | 2003-03-17 | 2010-04-28 | 株式会社メドジェル | 徐放性ハイドロゲル製剤 |
CA2544432C (en) * | 2003-11-04 | 2011-06-28 | Lek Pharmaceuticals D.D. | Stable pharmaceutical composition comprising granulocyte-colony stimulating factor |
CN1319525C (zh) * | 2004-09-16 | 2007-06-06 | 北京圣医耀科技发展有限责任公司 | 紫杉醇-海藻酸钠微球血管栓塞剂及其制备 |
CA2584553A1 (en) * | 2004-09-17 | 2006-03-23 | Cellgentech, Inc. | External agent for treatment of skin ulcer |
BRPI0515973B8 (pt) | 2004-10-12 | 2021-07-27 | Fmc Biopolymer As | kit para produzir um gel de alginato, composição para preparar um gel e uso |
US8318210B2 (en) * | 2005-02-28 | 2012-11-27 | Neos Therapeutics, Lp | Compositions and methods of making sustained release liquid formulations |
US9119901B2 (en) | 2005-04-28 | 2015-09-01 | Warsaw Orthopedic, Inc. | Surface treatments for promoting selective tissue attachment to medical impants |
US8414907B2 (en) | 2005-04-28 | 2013-04-09 | Warsaw Orthopedic, Inc. | Coatings on medical implants to guide soft tissue healing |
US8663686B2 (en) * | 2005-05-09 | 2014-03-04 | University Of Washington | Biodegradable chitosan-PEG compositions and methods of use |
WO2007102946A2 (en) | 2006-01-23 | 2007-09-13 | Amgen Inc. | Crystalline polypeptides |
CN101557801B (zh) * | 2006-07-14 | 2013-10-30 | Fmc生物聚合物联合股份有限公司 | 含有低分子量藻酸盐的水凝胶和从其制备的生物构建物 |
DE102007039871A1 (de) * | 2007-08-21 | 2009-02-26 | Friedrich-Baur-Gmbh | Weichgewebe-Implantat mit antibakterieller Wirkung |
JP2010537717A (ja) * | 2007-08-28 | 2010-12-09 | エフ エム シー コーポレーション | 遅効性自己ゲル化アルギネートシステムおよびその用途 |
ES2327375B1 (es) | 2007-11-14 | 2010-08-05 | Universidad Del Pais Vasco | Empleo de microparticulas para su uso como vacunas y la liberacion de moleculas biologicamente activas. |
US20090183503A1 (en) * | 2008-01-18 | 2009-07-23 | Alberto Verdesi | Exhaust apparatus |
WO2010009291A1 (en) * | 2008-07-16 | 2010-01-21 | Surmodics Pharmaceuticals, Inc. | Process for preparing microparticles containing bioactive peptides |
WO2010032242A1 (en) * | 2008-09-17 | 2010-03-25 | Beta O2 Technologies Ltd. | Optimization of alginate encapsulation of islets for transplantation |
EP2498763A4 (en) | 2009-11-09 | 2015-10-07 | Spotlight Technology Partners Llc | HYDROGELS BASED ON POLYSACCHARIDE |
US8795727B2 (en) | 2009-11-09 | 2014-08-05 | Spotlight Technology Partners Llc | Fragmented hydrogels |
US20130149349A1 (en) * | 2010-06-03 | 2013-06-13 | Indiana University Research And Technology Corporation | Use of compounds with thrombopoietic activity to promote bone growth and healing |
WO2011154941A2 (en) | 2010-06-07 | 2011-12-15 | Beta-O2 Technologies Ltd. | Multiple-layer immune barrier for donor cells |
US20130184835A1 (en) | 2010-07-09 | 2013-07-18 | Board Of Regents Of The Unversity Of Texas System | Biodegradable scaffolds |
SG10201701634PA (en) | 2011-03-25 | 2017-04-27 | Amgen Inc | Anti - sclerostin antibody crystals and formulations thereof |
CN102489027B (zh) * | 2011-12-12 | 2014-06-04 | 山东凯翔生物化工有限公司 | 一种葡萄糖酸内酯节能浓缩方法及装置 |
CN103830266A (zh) * | 2013-04-24 | 2014-06-04 | 杨亚勤 | 部分氧化海藻酸钠羧甲基化衍生物的制备方法和应用 |
RU2548777C2 (ru) * | 2013-07-09 | 2015-04-20 | Александр Александрович Кролевец | Способ получения частиц инкапсулированных жирорастворимой полимерной оболочкой солей металлов, обладающих супрамолекулярными свойствами |
WO2016010927A1 (en) | 2014-07-14 | 2016-01-21 | Amgen Inc. | Crystalline antibody formulations |
AU2015289967A1 (en) | 2014-07-14 | 2017-02-02 | Amgen Inc. | Crystalline antibody formulations |
US10835604B2 (en) * | 2015-08-13 | 2020-11-17 | Northeastern University | Biomaterials for combined radiotherapy and immunotherapy of cancer |
EP3501553A1 (en) * | 2017-12-21 | 2019-06-26 | Association for the Advancement of Tissue Engineering and Cell based Technologies & Therapies (A4TEC) - Associação | Hydrogel comprising manganese, methods and uses thereof |
CN109293138A (zh) * | 2018-10-08 | 2019-02-01 | 曹布道 | 一种养殖污水净化处理方法 |
US20220241193A1 (en) | 2019-06-21 | 2022-08-04 | Alfasigma S.P.A. | Pharmaceutical compositions in the form of gel containing xyloglucan and alcohols for the controlled release of active ingredients |
CN112426981B (zh) * | 2020-11-30 | 2021-12-28 | 西安交通大学 | 一种金属离子交联水凝胶及制备方法和应用 |
CN114685778B (zh) * | 2020-12-30 | 2023-10-17 | 苏州艾博生物科技有限公司 | 长循环阳离子脂质体的合成方法 |
CN112843328B (zh) * | 2021-02-25 | 2022-05-13 | 山东大学 | 一种具有抑菌作用的鲍鱼壳粉/ZnO复合材料掺杂的智能水凝胶伤口敷料的制备方法 |
CN114539442A (zh) * | 2022-04-02 | 2022-05-27 | 青岛海之林生物科技开发有限公司 | 一种脂溶性藻酸乙酯及其制备方法与应用 |
CN115850533B (zh) * | 2022-09-28 | 2023-07-21 | 青岛格诚经纬生物科技有限公司 | 一种海藻酸材料及其制备方法、应用 |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3640741A (en) * | 1970-02-24 | 1972-02-08 | Hollister Inc | Composition containing gel |
JPS5416979B2 (sh) * | 1972-01-08 | 1979-06-26 | ||
US4401456A (en) * | 1980-01-09 | 1983-08-30 | The United States Of America As Represented By The Secretary Of Agriculture | Controlled release of bioactive materials using alginate gel beads |
US4789516A (en) * | 1983-04-15 | 1988-12-06 | Damon Biotech, Inc | Production of sustained released system |
US4690682A (en) * | 1983-04-15 | 1987-09-01 | Damon Biotech, Inc. | Sustained release |
US4744933A (en) * | 1984-02-15 | 1988-05-17 | Massachusetts Institute Of Technology | Process for encapsulation and encapsulated active material system |
CA1215922A (en) * | 1984-05-25 | 1986-12-30 | Connaught Laboratories Limited | Microencapsulation of living tissue and cells |
US5147861A (en) * | 1986-06-30 | 1992-09-15 | Fidia S.P.A. | Esters of alginic acid |
JPS645460A (en) * | 1987-06-29 | 1989-01-10 | Sanei Kagaku Kogyo Kk | Production of delaying gelatinous material |
CA2121129A1 (en) * | 1991-10-29 | 1993-05-13 | Patrick Soon-Shiong | Crosslinkable polysaccharides, polycations and lipids useful for encapsulation and drug release |
US5656297A (en) * | 1992-03-12 | 1997-08-12 | Alkermes Controlled Therapeutics, Incorporated | Modulated release from biocompatible polymers |
GB2275686B (en) * | 1993-03-03 | 1997-04-30 | Johnson & Johnson Medical | Swellable wound dressing materials |
US5709854A (en) * | 1993-04-30 | 1998-01-20 | Massachusetts Institute Of Technology | Tissue formation by injecting a cell-polymeric solution that gels in vivo |
AU698393B2 (en) * | 1994-06-24 | 1998-10-29 | Immunex Corporation | Controlled release polypeptide compositions and methods of treating inflammatory bowel disease |
US5660859A (en) * | 1994-12-29 | 1997-08-26 | Mcneil-Ppc, Inc. | Gelling agent for polyethylene glycol |
WO1997015322A1 (en) * | 1995-10-25 | 1997-05-01 | The Regents Of The University Of California | Methods for restoring or enhancing reproductive function in reproductively impaired hosts |
US5831017A (en) * | 1996-01-25 | 1998-11-03 | Eli Lilly And Company | Obesity protein analog compounds and formulations thereof |
US6656508B2 (en) * | 1997-04-17 | 2003-12-02 | Amgen Inc. | Sustained-release alginate gels |
DE69838750T2 (de) * | 1997-05-16 | 2008-10-30 | Amgen Inc., Thousand Oaks | Zeitverzögerte gelzusammensetzungen mit verlängerter wirkstoffverabreichung |
GB2339442B (en) * | 1998-07-09 | 2002-06-05 | Smith International | Downhole tension swivel sub |
-
1998
- 1998-05-18 US US09/080,832 patent/US6432449B1/en not_active Expired - Fee Related
-
1999
- 1999-05-14 CA CA002331446A patent/CA2331446C/en not_active Expired - Fee Related
- 1999-05-14 IL IL13961799A patent/IL139617A0/xx unknown
- 1999-05-14 NZ NZ507943A patent/NZ507943A/en unknown
- 1999-05-14 PT PT99923091T patent/PT1079811E/pt unknown
- 1999-05-14 KR KR1020007012768A patent/KR20010025023A/ko not_active Application Discontinuation
- 1999-05-14 DK DK99923091T patent/DK1079811T3/da active
- 1999-05-14 DE DE69933763T patent/DE69933763T2/de not_active Expired - Fee Related
- 1999-05-14 SK SK1675-2000A patent/SK16752000A3/sk unknown
- 1999-05-14 EA EA200001200A patent/EA003670B1/ru not_active IP Right Cessation
- 1999-05-14 JP JP2000549214A patent/JP2002515419A/ja not_active Withdrawn
- 1999-05-14 EP EP99923091A patent/EP1079811B1/en not_active Expired - Lifetime
- 1999-05-14 HU HU0101895A patent/HUP0101895A3/hu unknown
- 1999-05-14 RS YUP-694/00A patent/RS49841B/sr unknown
- 1999-05-14 ES ES99923091T patent/ES2275341T3/es not_active Expired - Lifetime
- 1999-05-14 PL PL344337A patent/PL199499B1/pl unknown
- 1999-05-14 CN CN99808802A patent/CN1309556A/zh active Pending
- 1999-05-14 AU AU39939/99A patent/AU3993999A/en not_active Abandoned
- 1999-05-14 AT AT99923091T patent/ATE343378T1/de not_active IP Right Cessation
- 1999-05-14 BR BR9910553-5A patent/BR9910553A/pt not_active IP Right Cessation
- 1999-05-14 WO PCT/US1999/010737 patent/WO1999059549A1/en active IP Right Grant
-
2000
- 2000-11-03 ZA ZA200006299A patent/ZA200006299B/xx unknown
- 2000-11-03 NO NO20005564A patent/NO20005564L/no not_active Application Discontinuation
- 2000-11-14 BG BG104943A patent/BG65397B1/bg unknown
-
2002
- 2002-06-20 US US10/176,768 patent/US20020168406A1/en not_active Abandoned
-
2007
- 2007-01-24 CY CY20071100084T patent/CY1105944T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
PT1079811E (pt) | 2007-01-31 |
IL139617A0 (en) | 2002-02-10 |
BR9910553A (pt) | 2001-01-30 |
US6432449B1 (en) | 2002-08-13 |
AU3993999A (en) | 1999-12-06 |
US20020168406A1 (en) | 2002-11-14 |
HUP0101895A2 (hu) | 2001-10-28 |
KR20010025023A (ko) | 2001-03-26 |
ES2275341T3 (es) | 2007-06-01 |
WO1999059549A1 (en) | 1999-11-25 |
EP1079811B1 (en) | 2006-10-25 |
ATE343378T1 (de) | 2006-11-15 |
BG104943A (en) | 2001-07-31 |
NZ507943A (en) | 2003-08-29 |
CY1105944T1 (el) | 2011-04-06 |
SK16752000A3 (sk) | 2001-09-11 |
CA2331446A1 (en) | 1999-11-25 |
CA2331446C (en) | 2004-03-16 |
PL199499B1 (pl) | 2008-09-30 |
EA003670B1 (ru) | 2003-08-28 |
HUP0101895A3 (en) | 2004-01-28 |
DK1079811T3 (da) | 2007-02-26 |
JP2002515419A (ja) | 2002-05-28 |
DE69933763T2 (de) | 2007-10-04 |
NO20005564D0 (no) | 2000-11-03 |
EP1079811A1 (en) | 2001-03-07 |
NO20005564L (no) | 2001-01-18 |
EA200001200A1 (ru) | 2001-04-23 |
CN1309556A (zh) | 2001-08-22 |
PL344337A1 (en) | 2001-11-05 |
DE69933763D1 (de) | 2006-12-07 |
ZA200006299B (en) | 2001-05-30 |
BG65397B1 (bg) | 2008-06-30 |
RS49841B (sr) | 2008-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200006299B (en) | Biodegradable sustained-release alginate gels. | |
ZA983089B (en) | Sustained-release alginate gels | |
WO1998051348A3 (en) | Sustained-release delayed gels | |
MXPA01007710A (es) | Agente de secado por congelacion que contiene paramilon, su produccion y uso. | |
IL147803A0 (en) | 28-epirapalogs | |
BG101132A (en) | Pyridoanilated thienyl and furanyl oxazolidinons | |
MX9800625A (es) | Marcfortinas y paraherquamidas antiparasitarias. | |
HUP0000167A3 (en) | Pyrroles as spla2 inhibitors, and pharmaceutical compositions containing them | |
BG105437A (en) | REFLECTIVELY MODIFIED COMPOSITIONS AND METHODS FOR OBTAINING THEM | |
EP1056456A4 (en) | R-LANSOPRAZOL COMPOSITIONS AND TREATMENTS THEREFOR | |
ID23809A (id) | Komposisi-komposisi alginat yang dapat dituang | |
AU1915399A (en) | Cs-1 peptidomimetics, compositions and methods of using the same | |
EP1073333A4 (en) | S-RABEPRAZOL COMPOSITIONS AND METHODS | |
EP1139981A4 (en) | COMPOSITIONS AND RELATED METHODS OF USE | |
AU6849198A (en) | Neurotrypsin | |
ZA972708B (en) | Pharmaceutical compositions and methods for the manufacture thereof. | |
AU5623599A (en) | Aza-cyclodepsipeptides and their use as antiparasitics | |
EP1088067A4 (en) | TECHNIQUES AND COMPOSITIONS FOR MODULATING SPERMATOGENESIS | |
EP1073332A4 (en) | R-RABEPRAZOL COMPOSITIONS AND METHODS | |
AU3661799A (en) | Horticultural compositions comprising amphoteric polymers and methods of utilizing the horticultural compositions | |
AU2003200609A1 (en) | Biodegradable sustained-release alginate gels | |
AU1480801A (en) | Compositions and methods for the diminution or elimination of various cancers | |
AU2679599A (en) | Compositions and methods for modification of the gravitropic response of plants | |
EP1021610A4 (en) | PHOTO-STABILIZING POLYMER COMPOSITIONS AND PROCESSES FOR PRODUCING THE SAME | |
ZA972718B (en) | Compositions and methods for production of male-sterile plants. |